methylprednisolone has been researched along with Refractory Anemia in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, D; Inoue, M; Kikuchi, A; Kojima, S; Manabe, A; Nakahata, T; Ohara, A; Ohtsuka, Y; Tsuchida, M; Yagasaki, H | 1 |
| Asano, T; Cai, LZ; Hayakawa, J; Maeda, M; Migita, M; Orimoto, M; Ueda, T | 1 |
| Bourantas, KL; Chaidos, A; Christou, L; Gouva, M; Kapsali, E; Panteli, K; Tsiara, SN | 1 |
| Fujimi, A; Matsunaga, T; Murase, K; Niitsu, Y; Takahira, N; Takeuchi, N; Takimoto, R; Terui, T | 1 |
| Urabe, A | 1 |
| Bernini, JC; Buchanan, GR; Carrillo, JM | 1 |
| Amenomori, T; Iwanaga, M; Kawaguchi, Y; Kuriyama, K; Matsuo, T; Nakamura, H; Sadamori, N; Tomonaga, M | 1 |
| Annunziata, M; Copia, C; del Vecchio, L; di Noto, R; Ferrara, F; Palmieri, S; Russo, C; Spasiano, A | 1 |
| Chadburn, A; Kripas, C; Pastore, RD; Schattner, EJ | 1 |
| Kasajima, T; Mizoguchi, H; Motoji, T; Motomura, S; Nishikawa, T; Okutomi, K | 1 |
| Bessho, M; Hirashima, K; Jinnai, I; Kusumoto, S; Matsuda, A; Saito, M; Shiramatsu, F | 1 |
| Kusakabe, K; Mizoguchi, H; Motoji, T; Okada, M; Oshimi, K; Takahashi, M; Teramura, M | 1 |
| Ozsoylu, S | 1 |
| Azuno, Y; Fujii, S; Fujii, Y; Hiroshige, Y; Matsumoto, N; Ohkubo, M; Tanaka, H; Tanaka, M; Yaga, K; Yamada, K | 1 |
1 review(s) available for methylprednisolone and Refractory Anemia
| Article | Year |
|---|---|
[Myelodysplastic syndrome].
Topics: Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Antilymphocyte Serum; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methylprednisolone; Myelodysplastic Syndromes; Prognosis; World Health Organization | 2005 |
1 trial(s) available for methylprednisolone and Refractory Anemia
| Article | Year |
|---|---|
Treatment of children with refractory anemia: the Japanese Childhood MDS Study Group trial (MDS99).
Topics: Adolescent; Anemia, Refractory; Antilymphocyte Serum; Child; Child, Preschool; Chromosome Aberrations; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Male; Methylprednisolone; Neutropenia; Remission Induction; Survival Analysis | 2009 |
12 other study(ies) available for methylprednisolone and Refractory Anemia
| Article | Year |
|---|---|
Successful immunosuppressive therapy for a child with Myelodysplastic syndrome.
Topics: Anemia, Refractory; Anti-Inflammatory Agents; Antilymphocyte Serum; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Methylprednisolone; Myelodysplastic Syndromes | 2003 |
Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
Topics: Aged; Androgens; Anemia; Anemia, Refractory; Anti-Inflammatory Agents; Blood Transfusion; Bone Marrow Cells; Drug Therapy, Combination; Erythrocytes; Erythropoietin; Female; Humans; Male; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Nandrolone; Recombinant Proteins; Time Factors | 2004 |
[Successful corticosteroid treatment of thrombocytopenia in a pregnant woman with myelodysplastic syndrome (refractory anemia)].
Topics: Adult; Anemia, Refractory; Female; Humans; Methylprednisolone; Myelodysplastic Syndromes; Pregnancy; Pregnancy Complications, Hematologic; Puerperal Disorders; Purpura, Thrombocytopenic, Idiopathic | 2004 |
High-dose intravenous methylprednisolone therapy for patients with Diamond-Blackfan anemia refractory to conventional doses of prednisone.
Topics: Adolescent; Age of Onset; Anemia, Refractory; Anti-Infective Agents; Child, Preschool; Clinical Protocols; Dose-Response Relationship, Drug; Fanconi Anemia; Glucocorticoids; Humans; Infant; Methylprednisolone; Pneumocystis; Pneumocystis Infections; Prednisone; Prospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
A new translocation (4;12)(q21;q15) after combined immunosuppressive therapy in a case of hypoplastic myelodysplastic syndrome with translocation (12;15)(q23;q12)
Topics: Anemia, Refractory; Antilymphocyte Serum; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 4; Combined Modality Therapy; Cyclosporine; Humans; Immunosuppressive Agents; Karyotyping; Male; Methylprednisolone; Middle Aged; Translocation, Genetic | 1998 |
Complete remission of refractory anemia following a single high dose of cyclophosphamide.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Anemia, Refractory; Autoimmune Diseases; Blood Transfusion; Bone Marrow; Cyclophosphamide; Cyclosporine; Hematopoietic Stem Cell Mobilization; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methylprednisolone; Remission Induction | 1999 |
Novel association of haemophagocytic syndrome with Kaposi's sarcoma-associated herpesvirus-related primary effusion lymphoma.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anemia, Refractory; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Ganciclovir; Herpesvirus 8, Human; Histiocytosis, Non-Langerhans-Cell; Humans; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Sarcoma, Kaposi; Vincristine | 2000 |
Successful treatment of refractory anemia by high-dose methylprednisolone associated with an increment in CD68-positive cells in bone marrow.
Topics: Adult; Aged; Anemia, Refractory; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers; Bone Marrow Cells; Chi-Square Distribution; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Immunohistochemistry; Male; Methylprednisolone; Middle Aged; Prognosis; Survival Rate; Treatment Outcome | 2001 |
[Clinical features of atypical refractory anemia (RA)].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Refractory; Erythrocyte Aging; Female; Humans; Male; Methylprednisolone; Middle Aged; Prognosis | 1991 |
Successful treatment of refractory anemia with high-dose methylprednisolone.
Topics: Adult; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Dose-Response Relationship, Drug; Female; Humans; Karyotyping; Male; Methylprednisolone | 1990 |
High dose intravenous methylprednisolone for acquired aplastic anaemia, Diamond-Blackfan syndrome and aregenerative anaemias.
Topics: Adult; Anemia; Anemia, Aplastic; Anemia, Refractory; Child; Humans; Methylprednisolone; Primary Myelofibrosis; Red-Cell Aplasia, Pure | 1989 |
[Intravenous methylprednisolone pulse therapy in refractory anemia].
Topics: Adult; Aged; Anemia, Refractory; Blood Cell Count; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged | 1987 |